Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Immunology
Facteur d'impact: 1.352 Facteur d'impact sur 5 ans: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN Imprimer: 1040-8401
ISSN En ligne: 2162-6472

Volumes:
Volume 39, 2019 Volume 38, 2018 Volume 37, 2017 Volume 36, 2016 Volume 35, 2015 Volume 34, 2014 Volume 33, 2013 Volume 32, 2012 Volume 31, 2011 Volume 30, 2010 Volume 29, 2009 Volume 28, 2008 Volume 27, 2007 Volume 26, 2006 Volume 25, 2005 Volume 24, 2004 Volume 23, 2003 Volume 22, 2002 Volume 21, 2001 Volume 20, 2000 Volume 19, 1999 Volume 18, 1998 Volume 17, 1997 Volume 16, 1996 Volume 15, 1995 Volume 14, 1994

Critical Reviews™ in Immunology

Acheter le numéro $264.00 Volume 18, 1998 Numéro 1-2

DOI: 10.1615/CritRevImmunol.v18.i1-2

Table des matières:

PREFACE
M. Zouhair Atassi
vi pages
DOI: 10.1615/CritRevImmunol.v18.i1-2.10
T Cell Immunity to Tumor Antigens
Ingegerd Hellstrom , Karl Erik Hellstrom
pages 1-6
DOI: 10.1615/CritRevImmunol.v18.i1-2.20
Identification of Peptides for Immunotherapy of Cancer. It is Still Worth the Effort
Markwin P. Velders, John D. Nieland, Michael P. Rudolf, Kathleen Loviscek, Sanne Weijzen, Earin E. de Visser, M. Fatima Macedo, Michele Carbone, W. Martin Kast
pages 7-27
DOI: 10.1615/CritRevImmunol.v18.i1-2.30
p53-Based Immunotherapy of Cancer
Albert B. DeLeo
pages 29-35
DOI: 10.1615/CritRevImmunol.v18.i1-2.40
HER-2/neu Oncogenic Protein: Issues in Vaccine Development
Mary L. Disis, Martin A. Cheever
pages 37-45
DOI: 10.1615/CritRevImmunol.v18.i1-2.50
Strategies for Tumor Elimination by Cytotoxic T Lymphocytes
Linda A. Sherman, Matthias Theobald, David Morgan, Javier Hernandez, Igor Bacik, Jonathan Yewdell, Jack Bennink, Judith Biggs
pages 47-54
DOI: 10.1615/CritRevImmunol.v18.i1-2.60
Recognition of Melanoma-Derived Antigens by CTL: Possible Mechanisms Involved in Down-Regulating Anti-Tumor T-Cell Reactivity
Licia Rivoltini, Douglas J. Loftus, Paola Squarcina, Chiara Castelli, Francesca Rini, Flavio Arienti, Filiberto Belli, Francesco M. Marincola, Carsten Geisler, Alessandro Borsatti, Ettore Appella, Giorgio Parmiani
pages 55-63
DOI: 10.1615/CritRevImmunol.v18.i1-2.70
In Vitro Immunization and Expansion of Antigen-Specific Cytotoxic T Lymphocytes for Adoptive Immunotherapy Using Peptide-Pulsed Dendritic Cells
Van Tsai, Ichiro Kawashima, Elissa Keogh, Kieran Daly, Alessandro Sette, Esteban Celis
pages 65-75
DOI: 10.1615/CritRevImmunol.v18.i1-2.80
Tumor-Specific Immune Response: Current In Vitro Analyses May Not Reflect the In Vivo Immune Status
Florence Faure, Jos Even, Philippe Kourilsky
pages 77-86
DOI: 10.1615/CritRevImmunol.v18.i1-2.90
Dendritic Cells, Interleukin 12, and CD4+ Lymphocytes in the Initiation of Class l-restricted Reactivity to a Tumor/Self Peptide
Ursula Grohmann, Maria Cristina Fioretti, Roberta Bianchi, Maria Laura Belladonna, Emira Ayroldi, Daniela Surace, Silvia Silla, Paolo Puccetti
pages 87-98
DOI: 10.1615/CritRevImmunol.v18.i1-2.100
Dendritic Cell-Based Immunotherapy of Prostate Cancer
M. L. Salgaller, B. A. Tjoa, P. A. Lodge, H. Ragde, G. Kenny, A. Boynton, G. P. Murphy
pages 109-119
DOI: 10.1615/CritRevImmunol.v18.i1-2.120
Human Leukemia-derived Dendritic Cells: Ex-vivo Development of Specific Antileukemic Cytotoxicity
Aniruddha Choudhury, Antoine Toubert, Sapna Sutaria, Dominique Charron, Richard E. Champlin, David F. Claxton
pages 121-131
DOI: 10.1615/CritRevImmunol.v18.i1-2.130
Immunotherapy of Colon Cancer Using Chimeric mAb 31.1
Myron Arlen, Al Tsang, Tommy Wang
pages 133-138
DOI: 10.1615/CritRevImmunol.v18.i1-2.140
Tumor Cell Recognition by Lymphocytes: Is the MHC Always Essential?
Beverly Z. Packard , Akira Komoriya
pages 139-144
DOI: 10.1615/CritRevImmunol.v18.i1-2.150
TRANSCRIPT OF OPEN DISCUSSION
pages 145-152
DOI: 10.1615/CritRevImmunol.v18.i1-2.160

Critical Reviews™ in Immunology

Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Model for the recruitment of inducer-specific TNF-α gene enhanceosome in T lymphocytes., Vol. 29, Iss.2, Viral Mechanisms Involved in the TranscriptionalCBP/p300 Regulation of Inflammat..... Viral Mechanisms Involved in the Transcriptional CBP/р300 Regulation of Inflammatory and Immune Responses
Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Activation of several B cells is necessary for exosome release.Vol. 29, Iss. 3, Exosome Release by Primary B Cells. Exosome Release by Primary B Cells
Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Homology model of human GrM. Vol. 29, Iss. 4, The Biology of Granzyme M: A Serine Protease with Unique Features. Biology of Granzyme M: A Serine Protease with Unique Features
(A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. (A) Gap-junction formation, (B) A three-dimensional collagen matrix Vol. 30, Iss. 6, Endothelial Cells as Key Determinants of the Tumor Microenvironment. Endothelial Cells as Key Determinants of the Tumor Microenvironment: Interaction with Tumor Cells, Extracellular Matrix and Immune Killer Cells
Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30, Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Biphasic HCV RNA decline after IFN treatment of chronic hepatitis C. Vol. 30,  Iss. 2, Treatment of Hepatitis C Virus Infection with Interferon and Small Molecule Direct Antivirals. Treatment of Hepatitis C Virus Infection With Interferon and Small Molecule Direct Antivirals: Viral Kinetics and Modeling